Diplomat Pharmacy Inc DPLO Pharmaceuticals Healthcare Deals and Alliances...
SummaryDiplomat Pharmacy Inc Diplomat Pharmacy is a pharmaceutical company that provides medication management and clinical services. The company offers personalized medication therapies. Its services...
View ArticleNational Association of Specialty Pharmacy Dismisses PBMFunded Report...
WASHINGTON Aug. 4 2017 PRNewswireUSNewswire The National Association of Specialty Pharmacy's Executive Director Sheila Arquette released the following statement in response to the recent report...
View ArticleCalciMedica Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report...
SummaryCalciMedica Inc CalciMedica is a pharmaceutical company that develops small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The...
View ArticleTaiwanJ Pharmaceuticals Co Ltd 6549 Financial and Strategic SWOT Analysis...
SummaryTaiwanJ Pharmaceuticals Co Ltd TaiwanJ is a pharmaceutical company that develops and commercialize firstinclass small molecules as TLR4 antagonists. The company's TLR4 is a transmembrane protein...
View ArticleCYTOVIA Inc. IMMUNE Pharmas Oncology Subsidiary Announces the Publication of...
Strengthens Intellectual property portfolio and expands potential clinical use and market opportunity Cytovia the oncology subsidiary of Immune Pharmaceuticals NASDAQIMNP "Immune" or the Company a...
View ArticleArena Pharmaceuticals Provides Corporate Update and Reports Second Quarter...
SAN DIEGO Aug. 7 2017 PRNewswire Arena Pharmaceuticals Inc. Nasdaq ARNA a biopharmaceutical company focused on developing novel small molecule drugs across multiple therapeutic areas today provided a...
View ArticleQueens Medical Associates Provides Health Tips for Summer Sun Safety Month
Queens oncology and hematology center shares insight on protecting from skin cancerFresh Meadows NY PRWEB August 08 2017 As summer begins to wind down many Americans are looking to enjoy the remaining...
View ArticleSurvey of Payers and Gastroenterologists Finds Excitement Over the Prospect...
BURLINGTON Mass. Aug. 8 2017 PRNewswire Decision Resources Group finds that surveyed health insurance medical and pharmacy directors as well as gastroenterologists look favorably on Janus kinase JAK...
View ArticleNASP Responds to New ClassAction Lawsuit Filed Against CVS Health Alleging...
WASHINGTON Aug. 8 2017 PRNewswireUSNewswire A new classaction lawsuit filed against CVS Health alleges that the company knowingly colludes with third party pharmacy benefit managers PBMs to increase...
View ArticleProtagonist Therapeutics Reports Second Quarter 2017 Financial Results and...
NEWARK Calif. Aug. 8 2017 PRNewswire Protagonist Therapeutics Inc. Nasdaq PTGX today reported its financial results for the second quarter and six months ended June 30 2017. "Protagonist achieved...
View ArticleCYTOVIA Inc IMMUNE Pharmas Oncology Subsidiary Announces Publication of...
Additional potential in cancer immunotherapy with Ceplene in combination with Interleukin15 IL15 Cytovia the oncology subsidiary of Immune Pharmaceuticals Inc. NASDAQIMNP "Immune" a clinical stage...
View ArticleThe Crohns & Colitis Foundation and RMEI Medical Educations Clinical...
Improving collaborative management of IBD through evidencebased education The Clinical Convergence conference series entitled Patient and Provider Perspectives in IBD is expanding with three new...
View ArticleTxCell SA TXCL Financial and Strategic SWOT Analysis Review Report Updated...
SummaryTxcell SA Txcell is a biotechnology company that develops and innovates cellbased immunotherapy utilizing antigen specific regulatory Tcells. The company's pipeline products include cartreg...
View ArticleAevi Genomic Medicine Reports Second Quarter 2017 Financial Results
PHILADELPHIA Aug. 9 2017 PRNewswire Aevi Genomic Medicine Inc. NASDAQ GNMX the Company announced today financial and operational results for the quarter ended June 30 2017 and provided a corporate...
View ArticleAevi Genomic Medicine Announces Agreement for $28 Million Private Placement
PHILADELPHIA Aug. 10 2017 PRNewswire Aevi Genomic Medicine Inc. NASDAQ GNMX the "Company" today announced the execution of a definitive agreement to sell shares of common stock and warrants to purchase...
View ArticlePerianal fistulizing Crohn's disease pathogenesis diagnosis and therapy
Perianal fistulizing Crohn's disease has a major negative effect on a patient's quality of life and is a predictor of poor longterm outcome. Here the authors provide an uptodate overview on the...
View ArticleTumor Necrosis Factor Receptor Superfamily Member 5 B Cell Surface Antigen...
Tumor Necrosis Factor Receptor Superfamily Member 5 B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40 Pipeline Review H2 2017SummaryAccording to the recently published...
View ArticleRedHill Biopharma Ltd RDHL Financial and Strategic SWOT Analysis Review...
SummaryRedHill Biopharma Ltd RedHill is a biopharmaceutical company that develops and commercializes small molecule therapeutics in the areas of gastroenterology oncology and inflammation. The...
View ArticleMetabolomic Technologies Inc Medical Equipment Deals and Alliances Profile...
SummaryMetabolomic Technologies Inc MTI is a biotechnology company that develops metabolomicbased diagnostic systems. The company's products include ColoDx PolypDx BreastDx ProstateDx CeliacDx...
View ArticleNatco Pharma Ltd NATCOPHARM Financial and Strategic SWOT Analysis Review...
Natco Pharma Ltd NATCOPHARM Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
View Article